Providing the Clinical Excellence You Expect
Core of the Lab
A full complement of testing options is vital in managing the complexities of today’s laboratory requirements. Chemistry, immunochemistry, coagulation, and hematology systems that support a full spectrum of disease-state testing and innovative assays can help your lab meet unmet clinical needs.
Atellica Solution and Atellica CI 1900 System
Meeting the needs of labs today and in the future, the Atellica® Solution offers more than 210 assays. In addition to expanding our disease state portfolio with neurology and oncology assays, Siemens Healthineers offers strength in product performance, quality, portfolio breadth, and efficiency in workflow.
The Atellica® CI 1900 System1 is being developed for the lower-to-mid-volume laboratories. It is planned to utilize the same menu, reagents, consumables, and detection technology as the Atellica® Solution2. The Atellica CI 1900 System1 is being designed to take the lab a step beyond by offering the same workflow and IT across the network with the goal of redefining standardization.
Siemens Healthineers hematology systems provide accurate, first-pass results for laboratory hematology testing. Utilizing the concept of Practical Automation, laboratories can achieve optimum patient management, streamlined workflow and greater productivity, without large track-based systems, expensive stains or reflex testing.
The Atellica® IM B·R·A·H·M·S procalcitonin Assay helps achieve early sepsis risk assessment and aids in the management of antibiotic therapy.
Neurofilament light chains (sNfL) assay3 is intended to be used as an aid in identifying adult patients with Relapsing Multiple Sclerosis who are at lower vs higher risk of MS disease activity.
Anti-Mullerian Hormone3 is a fast and precise assay to assess ovarian reserve.
Core of a Healthy Community
Chronic-care testing and preventing the spread of infectious disease play an important role in improving the health of communities. A comprehensive, multidisciplinary laboratory test menu that includes COVID-19, hepatitis, oncology, coagulation and hematology assays is essential to help support a healthy community.
Developing accurate pediatric reference intervals is often impeded by limited availability of samples from healthy pediatric populations. Fast, accurate results with appropriate age-specific reference intervals from the laboratory can help physicians diagnose and determine treatment in a timely manner. Siemens Healthineers is committed to providing these reference intervals and supporting initiatives to protect the lives of our most vulnerable patients.
Core of Critical Care
Fast, accurate results are critical for acute-care and drug-testing patients. Laboratories need a full range of high-value testing options, including cardiac high-sensitivity troponin I and fentanyl for potentially life-threatening conditions, so that therapeutic measures can be implemented quickly and safely.
Accurate testing for both fentanyl and oxycodone is a community’s first line of defense in fighting the opioid epidemic. Siemens Healthineers is everywhere testing is needed: providing a reliable, rapid means to detect drugs of abuse, which can inform doctors, deter abuse, and help save lives.
ELF: A Simple Solution
The first and only biomarker granted FDA De Novo marketing authorization for prognosis of patients with advanced fibrosis due to NASH. The ELF™ Test is now Included in AACE NAFLD Clinical Practice Guidelines.
In development. Not available for sale. This is a conceptualization of development design goals. Future availability cannot be guaranteed.
Product availability varies by country.
Under development. Not commercially available. Future availability cannot be guaranteed.